NOMAD POWER SOLUTIONS, INC. Share-based Payment Arrangement, Expense
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Share-based Payment Arrangement, Expense of $622.61 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $622.61K, a 158.88% increase year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $82.18K, a 17.61% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $243.97K, a 212.88% increase year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $776.61K, a 626.98% increase year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense for fiscal 2025 was $1.39M, a 231.80% increase from fiscal 2024.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense for fiscal 2024 was $418.42K, a 45.88% decline from fiscal 2023.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense for fiscal 2023 was $773.20K, a 49.99% decline from fiscal 2022.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense for fiscal 2022 was $1.55M, a 29.77% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $622.61K 10-Q · filed 2026-08-14 | $704.79K 10-Q · filed 2026-08-14 | $948.76K derived: sum of 3 quarters · filed 2026-08-14 | $1.73M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $82.18K 10-Q · filed 2026-05-14 | $326.15K derived: sum of 2 quarters · filed 2026-05-14 | $1.10M derived: sum of 3 quarters · filed 2026-05-14 | $1.34M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $243.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.02M derived: sum of 2 quarters · filed 2026-03-31 | $1.26M derived: sum of 3 quarters · filed 2026-08-14 | $1.39M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $776.61K 10-Q · filed 2025-11-12 | $1.02M derived: sum of 2 quarters · filed 2026-08-14 | $1.14M 10-Q · filed 2025-11-12 | $1.19M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $240.50K 10-Q · filed 2026-08-14 | $268.00K 10-Q · filed 2025-08-07 | $312.74K 10-Q · filed 2026-08-14 | $367.74K 10-Q · filed 2025-08-07 | $418.21K derived: sum of 3 quarters · filed 2026-08-14 | $525.04K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $99.74K 10-Q · filed 2026-05-14 | $177.72K derived: sum of 2 quarters · filed 2026-05-14 | $284.54K derived: sum of 3 quarters · filed 2026-05-14 | $415.23K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $77.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $184.80K derived: sum of 2 quarters · filed 2026-03-31 | $315.50K derived: sum of 3 quarters · filed 2026-03-31 | $418.42K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $106.83K 10-Q · filed 2025-11-12 | $237.52K derived: sum of 2 quarters · filed 2025-11-12 | $340.44K 10-Q · filed 2025-11-12 | $444.50K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $130.69K 10-Q · filed 2025-08-07 | $233.62K 10-Q · filed 2025-08-07 | $337.68K derived: sum of 3 quarters · filed 2025-08-07 | $449.78K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $102.93K 10-Q · filed 2025-05-12 | $206.98K derived: sum of 2 quarters · filed 2025-05-12 | $319.09K derived: sum of 3 quarters · filed 2025-05-12 | $599.15K derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $104.06K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $216.16K derived: sum of 2 quarters · filed 2025-03-24 | $496.22K derived: sum of 3 quarters · filed 2025-03-24 | $773.20K 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $112.11K 10-Q · filed 2024-11-12 | $392.17K derived: sum of 2 quarters · filed 2024-11-12 | $669.15K 10-Q · filed 2024-11-12 | $1.05M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $280.06K 10-Q · filed 2024-08-08 | $557.04K 10-Q · filed 2024-08-08 | $942.43K derived: sum of 3 quarters · filed 2024-08-08 | $1.34M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $276.98K 10-Q · filed 2024-05-09 | $662.37K derived: sum of 2 quarters · filed 2024-05-09 | $1.06M derived: sum of 3 quarters · filed 2024-05-09 | $1.48M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $385.39K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $782.27K derived: sum of 2 quarters · filed 2024-03-19 | $1.21M derived: sum of 3 quarters · filed 2024-03-19 | $1.55M 10-K · filed 2024-03-19 | $1.50M 10-K · filed 2023-03-29 | |||
| 2022-09-30 | $396.88K 10-Q · filed 2023-11-09 | $820.98K derived: sum of 2 quarters · filed 2023-11-09 | $1.16M 10-Q · filed 2023-11-09 | $1.51M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $424.09K 10-Q · filed 2023-08-09 | $753.53K 10-Q · filed 2022-08-10 | $763.77K 10-Q · filed 2023-08-09 | $1.32M 10-Q · filed 2022-08-10 | $1.11M derived: sum of 3 quarters · filed 2023-08-09 | $1.46M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $339.67K 10-Q · filed 2023-05-10 | $686.89K derived: sum of 2 quarters · filed 2023-05-10 | $1.03M derived: sum of 3 quarters · filed 2023-05-10 | $2.10M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $347.22K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $694.44K derived: sum of 2 quarters · filed 2023-03-29 | $1.76M derived: sum of 3 quarters · filed 2023-03-29 | $2.20M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $347.22K 10-Q · filed 2022-11-08 | $540.97K 10-Q · filed 2021-11-10 | $1.41M derived: sum of 2 quarters · filed 2022-11-08 | $1.85M 10-Q · filed 2022-11-08 | $2.39M 10-Q · filed 2021-11-10 | $2.03M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $1.06M 10-Q · filed 2022-08-10 | $1.03M 10-Q · filed 2021-08-10 | $1.88M 10-Q · filed 2022-08-10 | $1.85M 10-Q · filed 2021-08-10 | $1.68M derived: sum of 3 quarters · filed 2022-08-10 | $2.14M derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $656.03K 10-Q · filed 2022-05-11 | $816.03K 10-Q · filed 2021-05-12 | $618.18K derived: sum of 2 quarters · filed 2022-05-11 | $1.08M derived: sum of 3 quarters · filed 2022-05-11 | $1.11M derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2020-12-31 | -$37.85K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $426.63K derived: sum of 2 quarters · filed 2022-03-21 | $453.63K derived: sum of 3 quarters · filed 2022-03-21 | $480.63K 10-K · filed 2022-03-21 | $765.09K 10-K · filed 2021-03-26 | |||
| 2020-09-30 | $464.48K 10-Q · filed 2021-11-10 | $491.48K derived: sum of 2 quarters · filed 2021-11-10 | $518.48K 10-Q · filed 2021-11-10 | $545.48K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $27.00K 10-Q · filed 2021-08-10 | $54.00K 10-Q · filed 2021-08-10 | $81.00K derived: sum of 3 quarters · filed 2021-08-10 | $113.03K derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $27.00K 10-Q · filed 2021-05-12 | $54.00K derived: sum of 2 quarters · filed 2021-05-12 | $86.03K derived: sum of 3 quarters · filed 2021-05-12 | $409.69K derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $59.03K derived: sum of 2 quarters · filed 2021-03-26 | $382.69K derived: sum of 3 quarters · filed 2021-03-26 | $422.63K 10-K · filed 2021-03-26 | $362.63K 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $32.03K 10-Q · filed 2020-11-10 | $17.03K 10-Q · filed 2019-11-08 | $355.69K derived: sum of 2 quarters · filed 2020-11-10 | $395.63K 10-Q · filed 2020-11-10 | $350.63K 10-Q · filed 2019-11-08 | $420.85K derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $323.67K 10-Q · filed 2020-08-10 | $296.67K 10-Q · filed 2019-08-06 | $363.60K 10-Q · filed 2020-08-10 | $309.60K 10-Q · filed 2019-08-06 | $388.82K derived: sum of 3 quarters · filed 2020-08-10 | $1.17M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2019-03-31 | $39.94K 10-Q · filed 2020-05-11 | $12.94K 10-Q · filed 2019-05-09 | $65.16K derived: sum of 2 quarters · filed 2020-05-11 | $849.55K derived: sum of 3 quarters · filed 2020-05-11 | $849.55K derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $25.22K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $809.61K derived: sum of 2 quarters · filed 2020-03-25 | $809.61K derived: sum of 3 quarters · filed 2020-03-25 | $833.61K 10-K · filed 2020-03-25 | $785.61K 10-K · filed 2019-03-25 | |||
| 2018-09-30 | $784.39K 10-Q · filed 2019-11-08 | $772.39K 10-Q · filed 2018-11-08 | $784.39K derived: sum of 2 quarters · filed 2019-11-08 | $808.39K 10-Q · filed 2019-11-08 | $772.39K 10-Q · filed 2018-11-08 | $817.38K derived: sum of 4 quarters · filed 2019-11-08 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | $32.99K derived: sum of 3 quarters · filed 2019-08-06 | $48.95K derived: sum of 4 quarters · filed 2019-08-06 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $32.99K derived: sum of 2 quarters · filed 2019-05-09 | $48.95K derived: sum of 3 quarters · filed 2019-05-09 | -$1.24K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $32.99K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $48.95K derived: sum of 2 quarters · filed 2019-03-25 | -$1.24K derived: sum of 3 quarters · filed 2019-03-25 | $70.69K 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | $15.96K 10-Q · filed 2018-11-08 | -$34.24K derived: sum of 2 quarters · filed 2018-11-08 | $37.70K 10-Q · filed 2018-11-08 | $30.73K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$50.20K 10-Q · filed 2018-08-02 | $21.74K 10-Q · filed 2018-08-02 | $14.77K derived: sum of 3 quarters · filed 2018-08-02 | $160.57K derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $71.94K 10-Q · filed 2018-04-27 | $64.97K derived: sum of 2 quarters · filed 2018-04-27 | $210.77K derived: sum of 3 quarters · filed 2018-04-27 | $389.47K derived: sum of 4 quarters · filed 2018-04-27 | ||||
| 2016-12-31 | -$6.97K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $138.83K derived: sum of 2 quarters · filed 2018-03-23 | $317.53K derived: sum of 3 quarters · filed 2018-03-23 | $287.16K 10-K · filed 2018-03-23 | ||||
| 2016-09-30 | $145.80K 10-Q · filed 2017-11-09 | $324.50K derived: sum of 2 quarters · filed 2017-11-09 | $294.13K 10-Q · filed 2017-11-09 | $417.43K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $178.69K 10-Q · filed 2017-08-04 | $148.32K 10-Q · filed 2017-08-04 | $271.63K derived: sum of 3 quarters · filed 2017-08-04 | $529.38K derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | -$30.37K 10-Q · filed 2017-05-10 | $92.93K derived: sum of 2 quarters · filed 2017-05-10 | $350.69K derived: sum of 3 quarters · filed 2017-05-10 | |||||
| 2015-12-31 | $123.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $381.06K derived: sum of 2 quarters · filed 2017-03-29 | $549.70K 10-K · filed 2017-03-29 | |||||
| 2015-09-30 | $257.76K 10-Q · filed 2016-11-04 | $426.40K 10-Q · filed 2016-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |